ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 94 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,000 | – | 19,025 | +11865.4% | 0.00% | – |
Q2 2023 | $0 | – | 159 | +448.3% | 0.00% | – |
Q1 2023 | $0 | – | 29 | 0.0% | 0.00% | – |
Q4 2022 | $0 | – | 29 | -66.7% | 0.00% | – |
Q3 2022 | $0 | – | 87 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 87 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 87 | +3.6% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 84 | -97.2% | 0.00% | – |
Q1 2021 | $16,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
Q4 2020 | $16,000 | +60.0% | 3,000 | +200.0% | 0.00% | – |
Q2 2020 | $10,000 | +66.7% | 1,000 | -48.6% | 0.00% | – |
Q1 2020 | $6,000 | +100.0% | 1,946 | -36.3% | 0.00% | – |
Q4 2019 | $3,000 | 0.0% | 3,054 | +52.7% | 0.00% | – |
Q3 2019 | $3,000 | -62.5% | 2,000 | 0.0% | 0.00% | – |
Q2 2019 | $8,000 | -20.0% | 2,000 | -8.9% | 0.00% | – |
Q1 2019 | $10,000 | -16.7% | 2,196 | +9.8% | 0.00% | – |
Q4 2018 | $12,000 | -14.3% | 2,000 | +100.0% | 0.00% | – |
Q3 2018 | $14,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
Q2 2018 | $12,000 | +9.1% | 1,000 | -1.6% | 0.00% | – |
Q1 2018 | $11,000 | – | 1,016 | +1463.1% | 0.00% | – |
Q4 2017 | $0 | – | 65 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |